These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 27556183)
21. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway. Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324 [TBL] [Abstract][Full Text] [Related]
22. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4. Wen SW; Zhang YF; Li Y; Xu YZ; Li ZH; Lü H; Zhu YG; Liu ZX; Tian ZQ Dig Dis Sci; 2018 Sep; 63(9):2285-2293. PubMed ID: 29781054 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner. Gai X; Zhao P; Pan Y; Shan H; Yue X; Du J; Zhang Z; Liu P; Ma H; Guo M; Yang X; Sun W; Gao L; Ma C; Liang X Int J Biochem Cell Biol; 2013 Jul; 45(7):1174-85. PubMed ID: 23542016 [TBL] [Abstract][Full Text] [Related]
24. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway. Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401 [TBL] [Abstract][Full Text] [Related]
25. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma. He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice. Tian F; Zhang C; Tian W; Jiang Y; Zhang X Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693 [TBL] [Abstract][Full Text] [Related]
28. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling. Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720 [TBL] [Abstract][Full Text] [Related]
29. Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling. Zhu DS; Dong JY; Xu YY; Zhang XT; Fu SB; Liu W Med Sci Monit; 2020 Aug; 26():e927106. PubMed ID: 32804918 [TBL] [Abstract][Full Text] [Related]
30. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells. Zhang J; Kong R; Sun L Biomed Pharmacother; 2017 Jul; 91():402-407. PubMed ID: 28472755 [TBL] [Abstract][Full Text] [Related]
31. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway. Li Z; Li Y; Jia Y; Ding B; Yu J Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637 [TBL] [Abstract][Full Text] [Related]
32. [Sensitivity of esophageal squamous cell carcinoma cells to rapamycin can be improved by siRNA-interfered expression of p70S6K]. Liu M; Lu Z; Zheng Y; Cui Y; Wang J; Hou G Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):885-9. PubMed ID: 26887615 [TBL] [Abstract][Full Text] [Related]
33. Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation. Li SH; Lu HI; Chang AY; Huang WT; Lin WC; Lee CC; Tien WY; Lan YC; Tsai HT; Chen CH Oncotarget; 2016 Oct; 7(41):67150-67165. PubMed ID: 27564102 [TBL] [Abstract][Full Text] [Related]
34. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma. Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477 [TBL] [Abstract][Full Text] [Related]
35. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977 [TBL] [Abstract][Full Text] [Related]
36. Targeted inhibition of mTOR signaling improves sensitivity of esophageal squamous cell carcinoma cells to cisplatin. Hou G; Yang S; Zhou Y; Wang C; Zhao W; Lu Z J Immunol Res; 2014; 2014():845763. PubMed ID: 24818169 [TBL] [Abstract][Full Text] [Related]
37. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma. Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090 [TBL] [Abstract][Full Text] [Related]
38. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma. Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009 [TBL] [Abstract][Full Text] [Related]
39. Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway. Shen Z; Xu L; Li J; Zhang N Med Sci Monit; 2017 May; 23():2096-2103. PubMed ID: 28463955 [TBL] [Abstract][Full Text] [Related]
40. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin. Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]